ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Detroit, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Breast Cancer

Lung Cancer trials near Detroit, MI, USA:

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

This is a single arm phase II trial enrolling patients with stage II-IIIA non-small cell lung cancer whose disease is deemed amenab...

Begins enrollment this month
Lung Cancer (NSCLC)
Drug: Cemiplimab
Drug: Adjuvant chemotherapy

Phase 2

Henry Ford Health
Henry Ford Health

Detroit, Michigan, United States

The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) exp....

Enrolling
Non-small Cell Lung Cancer Stage II
Non-Small Cell Lung Cancer Stage IIIA
Drug: Trastuzumab Deruxtecan

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Ann Arbor, Michigan, United States and 9 other locations

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Detroit, Michigan, United States and 90 other locations

(SG) and atezolizumab/durvalumab is effective in controlling cancer tumor growth in adults with extensive stage small cell lung...

Enrolling
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Small Cell Lung Cancer ( SCLC )
Drug: Sacituzumab govitecan
Drug: Atezolizumab

Phase 2

Bindu R Potugari

Detroit, Michigan, United States

The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...

Active, not recruiting
Advanced Non-Small Cell Lung Cancer
Drug: Docetaxel
Drug: Zimberelimab

Phase 2

Gilead Sciences
Gilead Sciences

Detroit, Michigan, United States and 50 other locations

This study has 2 cohorts: MOZART-ES cohort (for extensive-stage SCLC) and MOZART-LS cohort (for limited-stage SCLC).MOZART-ES cohort: Study treatment...

Enrolling
Small Cell Lung Cancer
Limited Stage Small-Cell Lung Cancer
Drug: Monalizumab
Drug: Etoposide

Phase 2

Hirva Mamdani

Detroit, Michigan, United States and 3 other locations

The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.

Enrolling
Extensive Stage Small Cell Lung Cancer
Drug: Tarlatamab

Phase 1

Amgen
Amgen

Ann Arbor, Michigan, United States and 30 other locations

Locations recently updated

to assess the safety and tolerability of BMS-986525 alone and in combination with Nivolumab in participants with Relapsed/Refractory Small Cell Lung...

Enrolling
Relapsed/Refractory Small Cell Lung Cancer
Drug: BMS-986525
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Detroit, Michigan, United States and 10 other locations

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Detroit, Michigan, United States and 210 other locations

locally advanced or metastatic disease.In addition, HER3-DXd will be evaluated in participants with locally advanced or metastatic NSCLC whose tumors...

Active, not recruiting
Non-Small Cell Lung Cancer (NSCLC)
Drug: HER3-DXd (FL-DP)
Drug: HER3-DXd (CTM-3 Lyo-DP)

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Detroit, Michigan, United States and 36 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems